Cite
HARVARD Citation
Ory, J. et al. (2022). Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy. Journal of urology. 207 (6), pp. 1295-1301. [Online].